Market revenue in 2023 | USD 204.8 million |
Market revenue in 2030 | USD 284.6 million |
Growth rate | 4.8% (CAGR from 2023 to 2030) |
Largest segment | Research & manufacturing |
Fastest growing segment | OUTPATIENT FACILITIES |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | OUTPATIENT FACILITIES, RESEARCH & MANUFACTURING, HOSPITALS |
Key market players worldwide | Jeol Ltd, Thermo Fisher Scientific Inc, Bruker Corp, Oxford Instruments PLC, Nanalysis Scientific Corp Ordinary Shares, Absci Corp, QuinStreet Inc, Magritek Ltd, Magnetic Resonance Innovations |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to nuclear magnetic resonance spectroscopy market will help companies and investors design strategic landscapes.
Research & manufacturing was the largest segment with a revenue share of 46.19% in 2023. Horizon Databook has segmented the U.S. nuclear magnetic resonance spectroscopy market based on outpatient facilities, research & manufacturing, hospitals covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. is anticipated to be the most lucrative market for NMR spectroscopy solutions, as it is the biggest market for biopharmaceuticals and a leader in biopharmaceutical R&D. According to the data published by PhRMA, the 15 major pharmaceutical companies invested USD 133 billion in 2021 in R&D, representing an increase of 44% since 2016.
Furthermore, the high prevalence of cancer and extensive R&D activities by regional players to develop novel therapies are expected to boost the demand for NMR spectroscopic solutions for diagnostic & research purposes.
In addition, following the outbreak of COVID‐ 19, several U.S.-based companies were involved in extensive research for developing novel vaccines and therapeutics. Hence, the demand for NMR spectroscopy for research purposes is predicted to surge.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. nuclear magnetic resonance spectroscopy market , including forecasts for subscribers. This country databook contains high-level insights into U.S. nuclear magnetic resonance spectroscopy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account